Want to join the conversation?
During 4Q15, $TMO's Life Sciences Solutions Segment revenue grew to $1.21Bil vs. $1.19Bil in 4Q14. Segment adjusted operating margin increased to 31.6%, versus 30.8% in 2014. Analytical Instruments Segment revenue rose 3% to $925MM compared to $902MM a year-ago quarter. Segment adjusted operating margin grew to 22.1% vs. 20.2% in 4Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?